MGB-23751-49754
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 060 / CT
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- 2FU-15259-72633
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Pfizer-BioNTech
-
2022-06-24
Registered in v-safe
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-29
- 2022-07-08
-
2022-07-13
Dose 2 — Pfizer-BioNTech
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-22
- 2022-07-29
- 2022-08-03
-
2022-08-12
Survey response — day 28, dose 2, dependentMedDRA: Herpangina, Medical counselling, Oral mucosal blistering, Pyrexia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Mouth blisters and a high fever that lasted three days. This was most likely Herpangina from the Coxsackie Virus, according to her pediatrician.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-12
Report sent to call center — day 28, dose 2, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-15
- 2022-08-19
-
2022-08-24
Survey response — day 42, dose 2, dependentMedDRA: Cough, Dysphonia, Nasal congestion, Oropharyngeal pain, Pyrexia — Feeling: FairFree text: Nasal congestion, sore throat, low grade fever, hoarseness, and mild cough.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Pfizer-BioNTech | No |
| 2 | 2022-07-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 28, dose 2, dependent
Symptoms: Mouth blisters and a high fever that lasted three days. This was most likely Herpangina from the Coxsackie Virus, according to her pediatrician.
Release 12 — day 42, dose 2, dependent
Symptoms: Nasal congestion, sore throat, low grade fever, hoarseness, and mild cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Herpangina | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oral mucosal blistering | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release